FDA Committee to Discuss Evidence, Marketing of NSAIDs for Pain After Cataract Surgery
From FDA
The FDA's Dermatologic and Ophthalmic Drugs Advisory Committee will convene on February 27 in Rockville, Maryland, to address topics related to the use of ophthalmic drug products. According to a news release, the committee will be asked to comment on the following topics: Appropriate types of clinical evidence for developing nonsteroidal anti-infl...
Login to read story
Friday, January 27, 2012
The John A. Moran Eye Center Receives Two Major Grants from ...
From John A. Moran Eye Center — 1/27/2012
Research to Prevent Blindness (RPB) has awarded two grants to the John A. Moran Eye Center (JMEC) at the University of Utah to support research into t...Full story
AMD Patients Had Improved Distance Acuity 10 Years After Cat...
From EyewireToday.com — 1/27/2012
Although clinical signs of age-related macular degeneration (AMD) at the time of cataract surgery were associated with longitudinally worse visual out...Full story
OJO Fortified Eye Care Nectar: The Visionary Drink
From Insightful Solutions, LLC — 1/27/2012
Insightful Solutions, LLC, established in 2009 in NY, developed OJO fortified eye care nectar under the direction of Dr. Jodi Luchs, MD, FACS, the fou...Full story
Visual Implant and Camera Give Blind Some Vision
From Medscape Ophthalmology — 1/27/2012
Ongoing trials of the Argus II Retinal Prosthesis System (Second Sight Medical Products) show that it returns useful visual perception to patients ren...Full story
Brain Receptor in Eyes May Link Epilepsy, Cataracts and Anti...
From University of Medicine and Dentistry ... — 1/27/2012
Researchers from the University of Medicine and Dentistry of New Jersey (UMDNJ) and Columbia University have discovered that the most common receptor ...Full story
Grant to UC San Diego Shiley Eye Center Supports Research in...
From UC San Diego — 1/27/2012
Research to Prevent Blindness (RPB) has awarded a grant of $100,000 to the Department of Ophthalmology at the University of California, San Diego Scho...Full story
Thursday, January 26, 2012
Temptime and Numedis Collaborate to Bring Proprietary Storag...
From Temptime Corp — 1/26/2012
Temptime Corp. and Numedis, Inc., the developers and manufacturers of advanced, high-performance corneal preservation systems, have collaborated to co...Full story
New Cases of Blindness from AMD Cut in Half Over Last Decade...
From University of Copenhagen — 1/26/2012
The risk of severe visual impairment and blindness from age-related macular degeneration (AMD) has been cut in half within the recent decade, in close...Full story
Roche Seen Offering Illumina More for Gene Mapping: Real M&A
From BusinessWeek — 1/26/2012
Roche Holding AG may need to raise its $5.7 billion bid for Illumina Inc. by the most of any North American takeover to gain access to its gene-mappin...Full story
Studies Reignite Debate over Avastin in Breast Cancer
From Medpage Today — 1/26/2012
Women with HER2-negative metastatic breast cancer had significantly higher rates of pathologic complete response (pCR) when bevacizumab (Avastin) was ...Full story
Wednesday, January 25, 2012
Iridex MicroPulse Laser Therapy Enhances Visual Function in ...
From Iridex Corp. — 1/25/2012
Iridex Corp. announced results of a clinical study evaluating the use of the Iridex MicroPulse laser therapy. The study examined the tissue-sparing th...Full story
Retinitis Pigmentosa In Dogs Cured By Gene Therapy
From Medical News Today — 1/25/2012
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retiniti...Full story
Researchers Develop Gene Therapy That Could Correct A Common...
From Medical News Today — 1/25/2012
A new gene therapy method developed by University of Florida researchers has the potential to treat a common form of blindness that strikes both young...Full story
Essilor Signs Two New Partnership Agreements in China
From Essilor — 1/25/2012
Essilor is pursuing its development in China with the signing of two new partnership agreements that represent approximately 22 million in additi...Full story
Evergreen Eye Center Introduces Groundbreaking Leica M22 Sur...
From Evergreen Eye Center — 1/25/2012
John Jarstad, MD, founder of Evergreen Eye Center, was the first US surgeon to use the new, Leica M822 Swiss microscope. The M822 is the latest versio...Full story
Roche Makes $5.7 Billion Offer for Illumina in Hostile Bid
From BusinessWeek — 1/25/2012
Roche Holding AG offered about $5.7 billion in cash for Illumina Inc. to bolster cancer-drug sales, the third time since 2007 the Swiss drugmaker has ...Full story
Haag-Streit UK Appoints a National Sales Manager to Drive th...
From Haag-Streit UK — 1/25/2012
Haag-Streit UK has announced the appointment of Grahame Wood as National Sales Manager. Grahame has been promoted from the position of regional sales ...Full story
Tuesday, January 24, 2012
Risk Of Blindness Halved Over Last Decade
From Medical News Today — 1/24/2012
Age-related macular degeneration (AMD) is the most frequent cause of blindness in the Western World. A report from the University of Copenhagen and Gl...Full story
IDEX Corporation Forms Optics & Photonics Platform
From IDEX Corp. — 1/24/2012
Driven by rising demand for custom-engineered solutions for photonics-enabled instrumentation, the IDEX Optics & Photonics (IOP) platform combines...Full story
TearLab Osmolarity System CLIA Waiver Issued by FDA
From TearLab Corp. — 1/24/2012
TearLab Corp. announced that, after reviewing and accepting labeling submitted to it by the company, the U.S. Food and Drug Administration has now gra...Full story
Stem Cell Therapy Safe in Macular Degeneration
From Medpage Today — 1/24/2012
In the first application of its kind, human embryonic stem cells were safely used to treat macular degeneration in two patients, researchers found. Th...Full story
Gene Therapy Research Cures Retinitis Pigmentosa in Dogs
From MedicalXpress — 1/24/2012
Members of a University of Pennsylvania research team have shown that they can prevent, or even reverse, a blinding retinal disease, X-linked Retiniti...Full story
Monday, January 23, 2012
Stem Cell Study May Show Advance
From The New York Times — 1/23/2012
A treatment for eye diseases that is derived from human embryonic stem cells might have improved the vision of two patients, bolstering the beleaguere...Full story
How Protein In Teardrops Annihilates Harmful Bacteria
From Medical News Today — 1/23/2012
A disease-fighting protein in our teardrops has been tethered to a tiny transistor, enabling UC Irvine scientists to discover exactly how it destroys ...Full story
PowerVision Closes Additional $12.5 Million Financing
From PowerVision — 1/23/2012
PowerVision, Inc., a private company developing an accommodating intraocular lens, announced that it had added Johnson & Johnson Development Corpo...Full story
NovaBay Prepares to Launch Global Phase 2b Ophthalmic Study ...
From NovaBay Pharmaceuticals, Inc. — 1/23/2012
NovaBay Pharmaceuticals, Inc., a clinical-stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local ...Full story
Bausch + Lomb and Topcon Partner to Deliver High Quality Sur...
From Bausch + Lomb — 1/23/2012
Bausch + Lomb Japan, a subsidiary company of Bausch + Lomb, and Topcon Medical Japan, a sales subsidiary company of Topcon, announced a key collaborat...Full story
Medicare Demo Projects Saved Little Money
From Medpage Today — 1/23/2012
Several demonstration projects aimed at saving the Medicare program money have yielded few positive results, according to a report from the Congressio...Full story
Diabetes Issues Key Topics at Congress
From Trade Arabia — 1/23/2012
The prevention and treatment of diabetes-related blindness and cataracts will be key topics at the upcoming World Ophthalmology Congress 2012 (WOC2012...Full story
Advertisement
- Glaucoma Specialist
Marietta, GA (Statewide)
Glaucoma specialist. General ophthalmology/cataract surgery if desired
- Caribbean Eye Meeting
Friday, February 03, 2012
The Ritz-Carlton, Grand Cayman, Cayman Islands - Ophthalmology Update 2012: New Approaches to Medical and Surgical Therapies
Friday, February 17, 2012
Omni San Diego Hotel
675 L Street
San Diego, CA 92101
